0,944  0,002  Muscle relaxant
0,934  0,002  Skeletal muscle relaxant
0,887  0,003  Spasmolytic
0,845  0,003  Cardiodepressant
0,813  0,005  Antileukemic
0,773  0,004  Histamine release inhibitor
0,768  0,004  Dopamine antagonist
0,761  0,005  Prostate cancer treatment
0,753  0,005  5 Hydroxytryptamine release stimulant
0,736  0,002  Pneumotoxic
0,729  0,004  5 Hydroxytryptamine antagonist
0,746  0,024  Apoptosis agonist
0,718  0,004  Dopamine D2 antagonist
0,709  0,017  Antineoplastic (lung cancer)
0,707  0,020  Antineoplastic (breast cancer)
0,694  0,021  Transcription factor NF kappa B inhibitor
0,679  0,008  Vasodilator, peripheral
0,671  0,003  Alpha 2 adrenoreceptor antagonist
0,621  0,004  Sigma receptor agonist
0,594  0,009  CYP2C19 inhibitor
0,586  0,005  P-glycoprotein inhibitor
0,566  0,014  Hepatic disorders treatment
0,549  0,005  Alpha adrenoreceptor antagonist
0,535  0,006  Anesthetic general
0,535  0,007  Antineoplastic (liver cancer)
0,522  0,002  Calcium antagonist
0,521  0,004  Acetylcholine nicotinic antagonist
0,533  0,023  Antidepressant
0,515  0,006  Antiseptic
0,510  0,003  Dopamine D1 antagonist
0,526  0,025  Respiratory analeptic
0,519  0,021  Radioprotector
0,502  0,015  CYP2D6 inhibitor
0,491  0,021  Caspase 3 stimulant
0,495  0,036  Antineoplastic (colorectal cancer)
0,486  0,033  Mood disorders treatment
0,470  0,017  Tumour necrosis factor alpha release inhibitor
0,454  0,005  Acetylcholine antagonist
0,482  0,036  Antineoplastic (colon cancer)
0,451  0,005  Cholinergic antagonist
0,452  0,008  Male reproductive disfunction treatment
0,443  0,005  Erectile dysfunction treatment
0,445  0,009  Antiparkinsonian, rigidity relieving
0,433  0,005  5 Hydroxytryptamine 1 antagonist
0,428  0,005  5 Hydroxytryptamine 1A antagonist
0,453  0,033  CYP2D6 substrate
0,423  0,011  Hepatoprotectant
0,412  0,018  Sedative
0,392  0,004  Neuronal nicotinic receptor antagonist
0,407  0,022  Vasodilator
0,424  0,044  Antiprotozoal (Plasmodium)
0,399  0,023  Psychostimulant
0,455  0,080  Caspase 9 stimulant
0,396  0,033  CYP3A4 inhibitor
0,362  0,010  Antiadrenergic
0,366  0,017  Proto-oncogene tyrosine-protein kinase Fyn inhibitor
0,353  0,010  Adrenaline antagonist
0,354  0,015  Antineoplastic (squamous cell carcinoma)
0,375  0,037  Hypoxia-inducible factor 1 alpha inhibitor
0,343  0,011  5 Hydroxytryptamine 1E antagonist
0,355  0,031  Antimitotic
0,408  0,090  Alzheimer's disease treatment
0,364  0,047  Antineoplastic (pancreatic cancer)
0,320  0,005  Dopamine agonist
0,325  0,014  5 Hydroxytryptamine 2 antagonist
0,327  0,016  Tubulin antagonist
0,311  0,004  Dopamine D2 agonist
0,316  0,010  5 Hydroxytryptamine 2A antagonist
0,357  0,053  Antipsychotic
0,307  0,004  Nicotinic receptor alpha3 subunit antagonist
0,341  0,054  Analeptic
0,361  0,079  Antineoplastic (myeloid leukemia)
0,356  0,076  CYP3A4 substrate
0,280  0,011  Alpha 2b adrenoreceptor antagonist
0,275  0,008  Alpha 2c adrenoreceptor antagonist
0,326  0,060  Cardioprotectant
0,302  0,036  Antineoplastic enhancer
0,266  0,007  Dopamine D3 antagonist
0,272  0,013  LDLR expression enhancer
0,309  0,054  Antipyretic
0,320  0,066  Antineoplastic (ovarian cancer)
0,262  0,009  Alpha 2a adrenoreceptor antagonist
0,340  0,097  Antiprotozoal
0,312  0,071  Antineoplastic (brain cancer)
0,293  0,060  DNA damaging
0,298  0,069  CYP1A2 substrate
0,226  0,008  Antineoplastic alkaloid
0,290  0,074  Antineoplastic (melanoma)
0,239  0,023  Toxic, respiratory center
0,222  0,009  Opioid kappa receptor antagonist
0,229  0,017  Alpha 1 adrenoreceptor antagonist
0,215  0,005  Dopamine D5 antagonist
0,227  0,018  Butyrylcholinesterase inhibitor
0,328  0,121  Antiparkinsonian
0,232  0,027  Topoisomerase II inhibitor
0,252  0,051  Nitric oxide antagonist
0,202  0,004  Nicotinic receptor alpha7 subunit antagonist
0,289  0,093  Antihypertensive
0,201  0,005  Calcium channel L-type blocker
0,209  0,014  Polo-like kinase-4 inhibitor
0,227  0,035  Cholinergic
0,212  0,030  CDC-like kinase 1 inhibitor
0,209  0,031  Acetylcholinesterase inhibitor
0,214  0,037  Cystic fibrosis treatment
0,180  0,005  Phosphodiesterase 11A inhibitor
0,180  0,005  Phosphodiesterase XI inhibitor
0,176  0,005  Antibiotic Glycopeptide-like
0,230  0,060  DNA methylase inhibitor
0,224  0,056  Neurotrophic factor enhancer
0,175  0,008  Phosphodiesterase V inhibitor
0,273  0,106  Apoptosis antagonist
0,208  0,042  Antineoplastic (carcinoma)
0,183  0,018  Alpha 1a adrenoreceptor antagonist
0,201  0,037  Uterine stimulant
0,174  0,012  CDC-like kinase 3 inhibitor
0,238  0,080  Antineoplastic (glioma)
0,165  0,009  Phosphodiesterase 5A inhibitor
0,185  0,030  5 Hydroxytryptamine 2B antagonist
0,199  0,043  Antiparkinsonian, tremor relieving
0,171  0,016  5 Hydroxytryptamine 7 antagonist
0,221  0,066  Antiarrhythmic
0,278  0,124  CYP2C9 substrate
0,161  0,008  Restless leg syndrome treatment
0,162  0,015  Electron transport complex I inhibitor
0,173  0,033  Topoisomerase I inhibitor
0,221  0,083  Free radical scavenger
0,203  0,067  Mutagenic
0,157  0,020  5 Hydroxytryptamine agonist
0,177  0,041  Calcium channel blocker
0,169  0,035  Acetylcholine muscarinic antagonist
0,151  0,023  Breast cancer-resistant protein inhibitor
0,150  0,026  Opioid antagonist
0,142  0,019  Phosphodiesterase I inhibitor
0,127  0,005  Potassium channel small-conductance Ca-activated blocker
0,159  0,038  Antiprotozoal (Amoeba)
0,125  0,003  Prolactin release inhibitor
0,136  0,021  Opioid mu receptor antagonist
0,132  0,019  Analgesic, opioid
0,130  0,021  5 Hydroxytryptamine 1F antagonist
0,135  0,029  Uric acid excretion stimulant
0,129  0,024  Histamine N-methyltransferase inhibitor
0,141  0,037  Constipation treatment
0,140  0,036  Antiviral (Influenza B)
0,116  0,015  Dopamine uptake inhibitor
0,204  0,110  Antioxidant
0,143  0,049  Antitussive
0,238  0,146  Vasodilator, coronary
0,158  0,067  Antiviral (Influenza A)
0,113  0,022  5 Hydroxytryptamine uptake inhibitor
0,112  0,022  Nicotinic alpha4beta2 receptor antagonist
0,114  0,028  Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor
0,091  0,005  Ryanodine receptor antagonist
0,095  0,010  Opioid kappa receptor agonist
0,155  0,070  Acetylcholine M1 receptor antagonist
0,105  0,025  Acetylcholine M4 receptor antagonist
0,089  0,010  Nicotinic receptor alpha4 subunit antagonist
0,093  0,016  Alpha tubulin antagonist
0,093  0,017  5 Hydroxytryptamine 5 antagonist
0,235  0,162  Cognition disorders treatment
0,099  0,027  Dopamine D4 antagonist
0,094  0,022  5 Hydroxytryptamine 1 agonist
0,090  0,019  5 Hydroxytryptamine 5A antagonist
0,183  0,113  Antineoplastic (cervical cancer)
0,082  0,012  5 Hydroxytryptamine 7 agonist
0,084  0,016  Potassium channel (Ca-activated) blocker
0,084  0,017  Opioid mu receptor agonist
0,086  0,020  Alpha 2 adrenoreceptor agonist
0,126  0,063  Alkylator
0,072  0,010  Factor III inhibitor
0,094  0,031  Opioid delta receptor antagonist
0,078  0,020  Opioid agonist
0,175  0,117  Antiprotozoal (Leishmania)
0,082  0,025  Glutamate (mGluR7) antagonist
0,116  0,060  DNA intercalator
0,087  0,034  Alpha adrenoreceptor agonist
0,192  0,139  Antineoplastic (sarcoma)
0,116  0,065  Interleukin 1b antagonist
0,195  0,145  Tyrosine 3 hydroxylase inhibitor
0,072  0,023  Sigma receptor antagonist
0,155  0,109  Antimigraine
0,069  0,025  Phosphodiesterase 1A inhibitor
0,189  0,145  CYP2C19 substrate
0,133  0,089  Genotoxic
0,050  0,006  Liver X receptor alpha antagonist
0,117  0,074  Antiviral (Hepatitis B)
0,265  0,223  Antineoplastic (solid tumors)
0,137  0,095  Antinephritic
0,071  0,029  5 Hydroxytryptamine 6 antagonist
0,076  0,036  5 Hydroxytryptamine 1B antagonist
0,053  0,015  Phosphodiesterase 6C inhibitor
0,062  0,024  Dopamine transporter inhibitor
0,142  0,105  Carcinogenic
0,066  0,030  Alpha 1 adrenoreceptor agonist
0,060  0,025  5 Hydroxytryptamine 1A agonist
0,081  0,046  Alpha 1b adrenoreceptor antagonist
0,039  0,005  Dopamine D1 agonist
0,047  0,014  Vesicle monoamine transporter inhibitor
0,060  0,027  5 Hydroxytryptamine 2 agonist
0,043  0,012  Liver X receptor antagonist
0,148  0,117  Antiviral (Influenza)
0,165  0,135  Antineoplastic (non-small cell lung cancer)
0,079  0,049  Narcotic antagonist
0,092  0,064  Prolactin inhibitor
0,153  0,129  Dependence treatment
0,220  0,198  Antineoplastic (small cell lung cancer)
0,033  0,012  Dopamine autoreceptor agonist
0,162  0,143  Antineoplastic (renal cancer)
0,134  0,115  Carcinogenic, group 1
0,156  0,138  Antineoplastic (lymphoma)
0,115  0,097  Papain-like protease (SARS coronavirus) inhibitor
0,034  0,016  Phosphodiesterase 6B inhibitor
0,062  0,044  5 Hydroxytryptamine 2A agonist
0,108  0,093  Anesthetic
0,087  0,073  Antiviral (Hepatitis A)
0,123  0,110  UGT2B7 substrate
0,052  0,038  5 Hydroxytryptamine 1B agonist
0,059  0,046  Acetylcholine M2 receptor antagonist
0,060  0,047  Protease activated receptor antagonist
0,036  0,024  Opioid delta receptor agonist
0,023  0,011  Endothelin B receptor antagonist
0,025  0,014  Phosphodiesterase 6H inhibitor
0,025  0,014  Phosphodiesterase 6G inhibitor
0,090  0,080  Nav1.1 sodium channel blocker
0,077  0,067  Antiprotozoal activity enhancer
0,054  0,044  Beta tubulin antagonist
0,110  0,100  Antiviral (Papilloma)
0,029  0,019  Endothelin receptor antagonist
0,139  0,131  Antineoplastic (glioblastoma multiforme)
0,143  0,136  Abortion inducer
0,163  0,160  5 Hydroxytryptamine 3E antagonist
0,215  0,212  Antibacterial
0,067  0,065  Topoisomerase II alpha inhibitor
0,019  0,018  Endothelin A receptor antagonist
0,080  0,079  Tocolytic

